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gEvery Rose Has Its Thorn” (1)
n this issue of iJACC, several articles focus on
the controversy of medical imaging radiation
(2–4). The debate on the “danger” of medical
imaging (5,6) has come to the forefront as a
esult of the rapid growth and wide scale applica-
ion of procedures exposing large segments of the
.S. population to ionizing radiation (7). For a
ardiac imaging procedure, a focus solely on the
isk of induced cancer can lead to imbalanced de-
ision-making and disregard for the incremental
etection of cardiac risk from procedures such as
omputed tomography (CT), single-photon emis-
ion computed tomography (SPECT), or positron
mission tomography (PET). We laud these arti-
les for providing a balanced discussion on cardiac
maging radiation. We hope that these papers
2–4) can inform key stakeholders on the scientific
rocess for evaluating the risks and benefits of car-
iac imaging. For all patients, the media, and
ealthcare advocacy groups to remain engaged and
nformed on this subject, the transparency of infor-
ation on medical imaging radiation is essential.
he emerging concept of patient-centered imaging
hould be extended to include important consider-
tions on appropriate and safe imaging including
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niversity of California Irvine, Irvine, California; #Departments of
edicine and Radiology, University of Virginia Health System, Char-
ottesville, Virginia; **Cleveland Clinic, Cleveland, Ohio; and the ††De-f
artment of Cardiology, The Methodist DeBakey Heart and Vascular
enter, Houston, Texas.eliberations on the benefits and risk of cardiac im-
ging (Fig. 1).
For CT, SPECT, or PET, the principle of “as
ow as reasonably achievable” (ALARA) have
uided the Food and Drug Administration ap-
roval process and developments in the field of
ardiac imaging. Considerable research has fo-
used on the development of dose reduction strat-
gies (8,9) including stress only SPECT imaging
10). When the published literature has identified
ower dose options (11), the cardiac imaging com-
unity has responded quickly. The dramatic reduc-
ion in the use of dual isotope SPECT imaging is
n example of how the cardiac imaging community
esponds promptly to employing alternative, lower
adiation dose testing.
Critical deficiencies remain in the quality of ev-
dence to guide effective use of all cardiac imaging
rocedures including ionizing radiation proce-
ures, such as CT, SPECT, or PET. Published
iscordance in quantifying effective doses for car-
iac imaging is one example in which accepted stan-
ards for measurement are not available (3,11,12).
n order to guide effective test decision making, we
eed to: 1) devise reliable measurement methods;
) develop a standard approach for extrapolating
igh- to low-dose exposure situations; 3) develop
ethods for estimating radiation-induced risks in
maging cohorts who have an elevated cancer risk
above that of the general population); and 4) create
eaningful effective dose categories that are risk-
ased and relevant to cardiac imaging.
The American College of Radiology has de-
ised a radiation risk level (RRL) that is inte-
rated within their appropriateness criteria. The
ocus of the RRL is to minimize patient radiation
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551xposure in test ordering and eliminate inappro-
riate imaging and unnecessary examinations
henever possible (13). The categories of the
RL correlate with expected cancer risk (14) and,
or cardiac imaging procedures, a test within the
to 10 mSv range has an expected induced can-
er risk of 1/10,000 (increased risk  0.01%) and
or a test from 10 to 100 mSv an expected cancer
isk of 1/1,000 (increased risk  0.1%). Many
ould argue that imaging exposure adds mini-
ally to our lifetime risk of cancer (1 in 2 for
en and 1 in 3 for women) (15). Yet, when ap-
lied to the more than 10 million patients that
ndergo cardiac imaging procedures, incident can-
er cases increase (nontrivially) by the thousands.
Given the enormous stakes, the subject of medi-
al imaging radiation requires considerably more
esearch than we have seen heretofore. It is funda-
ental to fully inform the public, referring physi-
ians, and policy experts on the benefits and risks of
ardiac imaging. The articles by Laskey (3), Gerber
4), and Halliburton (2) clearly articulate our lack of
rogress on dose measurement and cancer risk esti-
ation and the lack of standards for evaluating the
isks and benefits of cardiac imaging. We hope that
hese articles will spur further discussion on this
ubject. Our vision for the future includes a multi-
aceted approach to devise high quality evidence that
ay be clearly assimilated by patients and physicians
like. As a result, we need more guidance docu-
ents from cardiovascular specialty and imaging so-
ieties to synthesize current evidence and guide the
ffective use of cardiac imaging procedures that do
r do not expose patients to ionizing radiation. Theestimated risks from epidemiologic Img 2010;3:316–24ient educational websites that fully inform the pub-
ic on appropriate decision making on the risks and
enefits of cardiac imaging. For clinical research,
andatory inclusion of radiation safety as an end
oint would be an important goal and would further
ur understanding of radiation-induced risk. Cardiac
maging radiation should become a strategic priority
or funded research including comparative effective-
ess research evaluating nonionizing versus ionizing
adiation procedures. Clearly, we need research to
uide when a nonionizing radiation procedure can
e effectively and appropriately replaced with a non-
onizing procedure. Moreover, we need research on
he cumulative exposure as a result of repeat or lay-
red testing. Given the sizeable population at risk
or cardiovascular disease, such evidence would
reatly contribute to reducing cardiac morbidity and
ortality without disrupting projected national sta-
Figure 1. The Potential Relationship Between the Beneﬁt of Car
Harm Associated With Medical Imaging Radiation in Younger a
As a patient ages, the relative harm associated with medical imagin
decreases due to the decreased lifetime cancer risk and is lowest in
beneﬁt is proposed to increase with the prevalence of coronary art
greatest for middle-aged to elderly patients. Radiation-induced can
younger patients and, as such, the risk may exceed any beneﬁt. Wh
to appropriate patients and indications, the beneﬁt exceeds the haardiac imaging community also needs to devise pa- tistics for cancer incidence.1E F E R E N C E S
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